Severe Mucocutaneous Candidiasis
1 clinical trials · Condition
◉ Watch Severe Mucocutaneous Candidiasis
| Record | Firm | Date |
|---|---|---|
| Rituximab for Anti-cytokine Autoantibody-Associated Diseases (NCT01842386) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-04-29 |
Track Severe Mucocutaneous Candidiasis automatically
Every clearance here is in the API, with alerts when new ones post.